ADC Therapeutics SA Gross Profit Growth & History (ADCT)
ADC Therapeutics SA's gross profit was $75.6M for fiscal 2025.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $75.6M | $10.7M | +16.45% |
| 2024 | 2024-12-31 | $64.9M | −$1.6M | −2.47% |
| 2023 | 2023-12-31 | $66.5M | −$138.8M | −67.60% |
| 2022 | 2022-12-31 | $205.3M | $172.8M | +531.32% |
| 2021 | 2021-12-31 | $32.5M | $32.5M | — |
| 2020 | 2020-12-31 | $0 | −$2.3M | — |
| 2019 | 2019-12-31 | $2.3M | — | — |
ADC Therapeutics SA quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.9M | −$1.1M | −6.13% |
| Q1 2026 | 2026-03-31 | $17.2M | −$3.7M | −17.81% |
| Q4 2025 | 2025-12-31 | $21.4M | — | — |
| Q3 2025 | 2025-09-30 | $15.2M | — | — |
| Q2 2025 | 2025-06-30 | $18.0M | — | — |
| Q1 2025 | 2025-03-31 | $21.0M | — | — |
| Q4 2023 | 2023-12-31 | $16.0M | −$53.3M | −76.86% |
| Q3 2023 | 2023-09-30 | $14.1M | −$60.9M | −81.17% |
| Q2 2023 | 2023-06-30 | $18.0M | $2.9M | +19.56% |
| Q1 2023 | 2023-03-31 | $18.4M | −$27.6M | −59.97% |
| Q4 2022 | 2022-12-31 | $69.3M | $53.1M | +326.78% |
| Q3 2022 | 2022-09-30 | $75.0M | $62.4M | +493.33% |
| Q2 2022 | 2022-06-30 | $15.0M | $11.4M | +312.89% |
| Q1 2022 | 2022-03-31 | $46.0M | $46.0M | — |
| Q4 2021 | 2021-12-31 | $16.2M | — | — |
| Q3 2021 | 2021-09-30 | $12.6M | $12.6M | — |
| Q2 2021 | 2021-06-30 | $3.6M | $3.6M | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
ADC Therapeutics SA gross profit trends
Over the last five fiscal years, ADC Therapeutics SA's gross profit increased from $0 to $75.6M, a change of $75.6M. The latest reported quarter, Q2 2026, shows $16.9M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗